228
Participants
Start Date
May 1, 2025
Primary Completion Date
December 31, 2027
Study Completion Date
December 31, 2028
Blood pressure treatment algorithm
Single or combination antihypertensive therapy as needed: 1) amlodipine (2.5-10 mg), 2) telmisartan (20-80 mg) or losartan (25-100 mg), 3) chlorthalidone (6.25-25 mg), or 4) spironolactone (12.5-50 mg). a two-drug regimen with either amlodipine + chlorthalidone or telmisartan + chlorthalidone will be initiated following randomization. If a diuretic is contraindicated, amlodipine + telmisartan will be initiated. For those over 75 years, either amlodipine or telmisartan will be initiated at baseline if SBP is \<140 mmHg. In the standard treatment group (SBP goal of \< 140 mmHg), participants will either be prescribed amlodipine or telmisartan/losartan as initial therapy. If \>3 medications are necessary to reach the intensive goal and no first line options remain, potassium sparing diuretics or direct vasodilators will be considered.
ENROLLING_BY_INVITATION
Birmingham VA Medical Center, Birmingham, AL, Birmingham
ENROLLING_BY_INVITATION
Tennessee Valley Healthcare System Nashville Campus, Nashville, TN, Nashville
RECRUITING
William S. Middleton Memorial Veterans Hospital, Madison, WI, Madison
VA Tennessee Valley Health Care System
FED
Birmingham, Alabama VA Medical Center
FED
The Lundquist Institute
UNKNOWN
University of Wisconsin, Madison
OTHER
VA Office of Research and Development
FED